![The Radcliffe Cardiology Podcast](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-01/DELV-4317_IND_RadcliffePodcast_Brand_1080x1080%20%281%29.png?VersionId=0_xtiGz.9E0.ktP3ZIVRPtq5FM11oxcn)
The Radcliffe Cardiology Podcast
The Radcliffe Cardiology Podcast brings you the latest advancements, research and best practices in the field of cardiology. Each episode features expert insights and engaging discussions with leading healthcare professionals, covering a breadth of topics in cardiovascular science.
Our podcast aims to build on the best science, with key takeaways from the top cardiology conferences and recent publications from our journals.
Read MoreRead Less
All Episodes
![Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6313_NN_Kaski_Badimon_1920x1080_1.png?VersionId=NM38Vmrhd0rZkhpzvUCJ8Aj.5OoHyTxR&itok=z6D7Qx1D)
Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.
Read More
![Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6311_NN_Kaski_Libby_1920x1080.png?VersionId=CHVUI5Z6H9WM.EwmBKOybAd6OgTBpNLB&itok=wIYL79P-)
Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.
Read More
![Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6312_NN_PP_Kaski_Ridker_Video2_1920x1080.png?VersionId=l4AvxX2wcAv0mjZ8HRrckn2.tQxPOoKd&itok=PcE6IpOJ)
Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
![Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6312_NN_PP_Kaski_Ridker_Video1_1920x1080.png?VersionId=o6Ai1eALt9goiQGMnx3u011gF5Lik1Gr&itok=aGaoYZr7)
Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.
Read More
![Targeting Inflammation in Atherosclerosis: COLCOT Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6319_NN_Tardif_1920x1080.png?VersionId=IZkLxvnDuTsja5S6DvQZ1xpITal5wiu4&itok=XK-jErQu)
Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.
Read More
![Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6316_NN_Fiolet_1920x1080.png?VersionId=AL_yCpLqvIZMkLbADH_U3FeRdEkaA_fD&itok=h9afQebj)
In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
![Targeting Inflammation in Atherosclerosis: RESCUE Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6318_NN_Libby_1920x1080.png?VersionId=2HrXL_1dVMbJ9BJrgEizEE2AotHOWbYt&itok=9UTzPFNn)
Join Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) as he talks us through the RESCUE trial design and results in this short podcast.
Read More
![Targeting Inflammation in Atherosclerosis: CANTOS Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6317_NN_Ridker_1920x1080.png?VersionId=BgTEwlHOTtN9IR0YhA3XyQs1_ZBQDD_p&itok=WJnbP8uu)
Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022.
Read More
![Ep 5: Invasive Diagnosis of Coronary Functional Disorder](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-7457_ECR_EP_5_1920x1080%20v3.png?VersionId=IAiK7R0cREVP1Gq471L8LCSsiRQZpbx5&itok=ARtHzoxY)
Did you know that coronary vasomotion disorders are a frequent cause of angina in patients with non-obstructed coronary arteries? In this month's episode of the ECR podcast, Dr Andreas Seitz and Dr Peter Ong (Robert-Bosch Hospital, Stuttgart, DE) return to discuss their recent article on the diagnosis of coronary disorders which cause angina (https://www.ecrjournal.com/articles/invasive-diagnosis-coronary-functional-disorders-causing-angina-pectoris) from ECR Journal.
Read More
![Ep 4: The EXCEL Trial: The Interventionalists’ Perspective](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-5953_ECR_EP_4_1920x1080%20v3.png?VersionId=S3ZFF0CWhO9XD4zbfg402A8aoXUsnzgn&itok=A4Q6m6BN)
In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today.
Read More
![Ep 9: Sex Differences in Hypertension: Pharmacological Treatment](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9601_ECR_EP_9_1920x1080%20v3.png?VersionId=nCxO.HFAMlDaoa97AIyluRc.84J.YW8d&itok=vDNVphfl)
In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations.
Read More
![Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9963_ECR_EP_8_1920x1080%20v3.png?VersionId=H_PpHdkBlsXWwIM3CU7OKBWfwKsIMhOC&itok=O0IMbo0q)
What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?
In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
Read More
In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
![Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9732_ECR_EP_7_1920x1080%20v3.png?VersionId=fgC9qTTpBbEunJ3lA84.aIkG9IzVbjOr&itok=CFcrw78V)
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.
Read More
![Ep 6: Inflammatory Biomarkers and Cardiovascular Risk](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9377_ECR_EP_6_1920x1080%20v3.png?VersionId=2TBpob7jjjEZqtHM9MlG6vf3aq2uUdnt&itok=zCk6OoPd)
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Read More
![Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6314_NN_Kaski_Fiolet_1920x1080.png?VersionId=zzBXlqg17rbiXsBjYW5OHA7u7mXUg3qd&itok=8f3Ze18J)
Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.